Autoimmune Diseases

A Wealth of Experience

We have collaborated with our clients on projects to research autoimmune diseases, autoimmune treatments, and complications and comorbidities of autoimmune disorders. 

Our experience includes:

  • Celiac disease
  • Immunoglobulin treatments
  • Lupus erythematosus
  • Psoriatic arthritis

Types of Projects

We have implemented studies to help our clients develop strategies in the autoimmune market and to develop and gain 
market access for products to treat autoimmune diseases and complications arising from treatment of autoimmune illnesses.

Recent projects have included:

Our Experts

Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Patricia Sacco
Senior Director, Surveys and Observational Studies
Chris Knight
Senior Director, Health Economics
Ari Gnanasakthy
Principal Scientist, Patient-Centered Outcomes Assessment
Mary Anthony
Director, Epidemiology
Evelina Zimovetz
Associate Director, Market Access and Outcomes Strategy
Anne Heyes
Vice President, Head Market Access and Outcomes Strategy - Europe
Jin Yang
Senior Associate, Market Access and Outcomes Strategy
Colleen Castro
Senior Associate, Market Access and Outcomes Strategy
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Donald Stull
Head, Data Analytics and Design Strategy
Diane Whalley
Senior Director, Patient-Centered Outcomes Assessment

Selected Recent Autoimmune Diseases Publications

Mease PJ, Gladman DD, Davenport EK, Zhou X, Guerette B, Teng L, Kaura S, Nash P. Improvements in work productivity with up to 104 weeks of apremilast monotherapy: results from a phase 3b, randomized, controlled study in biologic-naive subjects with active psoriatic arthritis. Poster presented at the 5th World Psoriasis & Psoriatic Arthritis Conference 2018; June 27, 2018. Stockholm, Sweden. [abstract] Acta Derm Venereol. 2018 Jun; 98(Suppl 219):14. doi: 10.2340/00015555-2978. Previously presented at the 2017 ACR/ARHP Annual Meeting.